134 related articles for article (PubMed ID: 2361594)
1. Electroretinographic findings in panretinal photocoagulation for diabetic retinopathy. A randomized study with blue-green argon and red krypton lasers.
Capoferri C; Bagini M; Chizzoli A; Pece A; Brancato R
Graefes Arch Clin Exp Ophthalmol; 1990; 228(3):232-6. PubMed ID: 2361594
[TBL] [Abstract][Full Text] [Related]
2. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
Blankenship GW
Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
[TBL] [Abstract][Full Text] [Related]
3. Red krypton and blue-green argon laser diabetic panretinal photocoagulation.
Blankenship GW; Gerke E; Batlle JF
Graefes Arch Clin Exp Ophthalmol; 1989; 227(4):364-8. PubMed ID: 2476366
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.
Ophthalmology; 1993 Nov; 100(11):1655-64. PubMed ID: 8233391
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of argon green and krypton red laser photocoagulation for patients with diabetic exudative maculopathy.
Khairallah M; Brahim R; Allagui M; Chachia N
Br J Ophthalmol; 1996 Apr; 80(4):319-22. PubMed ID: 8703882
[TBL] [Abstract][Full Text] [Related]
6. Argon versus krypton panretinal photocoagulation side effects on the anterior segment.
Menchini U; Scialdone A; Pietroni C; Carones F; Brancato R
Ophthalmologica; 1990; 201(2):66-70. PubMed ID: 2234817
[TBL] [Abstract][Full Text] [Related]
7. Retinal function of the diabetic retina after argon laser photocoagulation assessed electroretinographically.
Perlman I; Gdal-On M; Miller B; Zonis S
Br J Ophthalmol; 1985 Apr; 69(4):240-6. PubMed ID: 4039601
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological studies before and after argon-laser photocoagulation in diabetic retinopathy.
François J; De Rouck A; Cambie E; Castanheira-Dinis A
Ophthalmologica; 1977; 176(3):133-44. PubMed ID: 565904
[TBL] [Abstract][Full Text] [Related]
9. Treatment of diffuse diabetic macular oedema: a comparison between argon and krypton lasers.
Casswell AG; Canning CR; Gregor ZJ
Eye (Lond); 1990; 4 ( Pt 5)():668-72. PubMed ID: 2282940
[TBL] [Abstract][Full Text] [Related]
10. Treatment of proliferative diabetic retinopathy. Long-term results of argon laser photocoagulation.
Little HL
Ophthalmology; 1985 Feb; 92(2):279-83. PubMed ID: 2580259
[TBL] [Abstract][Full Text] [Related]
11. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.
Blankenship GW
Ophthalmology; 1988 Feb; 95(2):170-7. PubMed ID: 2459641
[TBL] [Abstract][Full Text] [Related]
12. Panretinal photocoagulation in diabetic retinopathy: argon versus dye laser coagulation.
Seiberth V; Schatanek S; Alexandridis E
Graefes Arch Clin Exp Ophthalmol; 1993 Jun; 231(6):318-22. PubMed ID: 8339946
[TBL] [Abstract][Full Text] [Related]
13. Krypton laser for proliferative diabetic retinopathy: the Krypton Argon Regression of Neovascularization Study.
Singerman LJ; Ferris FL; Mowery RP; Brucker AJ; Murphy RP; Lerner BC; Mincey GJ
J Diabet Complications; 1988; 2(4):189-96. PubMed ID: 2466855
[TBL] [Abstract][Full Text] [Related]
14. Fifteen-year argon laser and xenon photocoagulation results of Bascom Palmer Eye Institute's patients participating in the diabetic retinopathy study.
Blankenship GW
Ophthalmology; 1991 Feb; 98(2):125-8. PubMed ID: 2008268
[TBL] [Abstract][Full Text] [Related]
15. Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema.
Olk RJ
Ophthalmology; 1990 Sep; 97(9):1101-12; discussion 1112-3. PubMed ID: 2234840
[TBL] [Abstract][Full Text] [Related]
16. [Observation on clinical effects of panretinal coagulation for diabetic retinopathy].
Qian Z; Zhu L; Zhao C
Yan Ke Xue Bao; 2002 Jun; 18(2):99-101. PubMed ID: 15510646
[TBL] [Abstract][Full Text] [Related]
17. Function of the diabetic retina after panretinal argon laser photocoagulation. Influence of the intensity of the coagulation spots.
Seiberth V; Alexandridis E
Ophthalmologica; 1991; 202(1):10-7. PubMed ID: 2017326
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group.
Arch Ophthalmol; 1994 Sep; 112(9):1176-84. PubMed ID: 7522004
[TBL] [Abstract][Full Text] [Related]
19. Argon green and krypton red laser treatment of diabetic macular edema.
Cruess AF; Williams JC; Willan AR
Can J Ophthalmol; 1988 Oct; 23(6):262-6. PubMed ID: 3203238
[TBL] [Abstract][Full Text] [Related]
20. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.
Blankenship GW
Trans Am Ophthalmol Soc; 1987; 85():176-94. PubMed ID: 2451871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
